Zentel Chewable Tablet contains Albendazole 400mg, an anthelmintic agent effective against a broad spectrum of parasitic worm infestations. Albendazole acts by inhibiting the polymerization of tubulin into microtubules, disrupting essential cellular processes in helminths, leading to their immobilization and eventual death. Zentel Chewable Tablet is indicated for the treatment of various helminthic infections, including neurocysticercosis, hydatid disease, ascariasis, hookworm infections, trichuriasis, and giardiasis. The chewable formulation facilitates administration, particularly in pediatric patients or those with difficulty swallowing tablets. It is recommended to be taken with food to enhance absorption. The dosage and duration of therapy depend on the type and severity of the infection and should be determined by a healthcare professional. Common adverse effects may include abdominal pain, nausea, vomiting, headache, and dizziness, which are generally mild and transient. Caution is advised in patients with liver impairment or hematologic abnormalities. Albendazole is contraindicated during the first trimester of pregnancy due to potential teratogenicity. Regular monitoring of liver function tests and blood counts is recommended during prolonged therapy. Zentel Chewable Tablet should be used under medical supervision to ensure efficacy and safety in the management of parasitic infections.